Search Tag: pancreatic cancer
2025 29 Sep
Centralisation of pancreatic surgery has improved postoperative outcomes in several countries, yet it has also intensified the fragmentation that patients and clinicians experience when care spans expert and non-expert centres. Multiple handovers, repeated diagnostics and delays to diagnosis and treatment are recurrent consequences, compounded...Read more
2025 25 Aug
Pancreatic ductal adenocarcinoma remains one of the deadliest malignancies, largely due to its frequent diagnosis at advanced stages. While contrast-enhanced computed tomography remains the standard imaging method for pancreatic cancer evaluation, nearly 40% of early-stage tumours can still go undetected. Deep learning approaches have emerged...Read more
2025 21 Jul
Pancreatic ductal adenocarcinoma (PDAC) is characterised by high malignancy and a notably poor prognosis, with early lymph node metastasis (LNM) serving as a key prognostic factor. Current clinical guidelines recommend dissection of at least 15 lymph nodes during surgery, though survival remains low, especially in patients with extensive dissection...Read more
2025 06 Jul
Pancreatic cancer remains one of the deadliest malignancies, with a five-year survival rate of just 11%. While most cases are sporadic, a notable subset arises in individuals with hereditary or familial predispositions. These high-risk individuals (HRIs) face a significantly elevated lifetime risk of developing pancreatic cancer. Early detection...Read more
2024 17 May
In locally advanced pancreatic cancer (LAPC), preventing local progression is crucial as it significantly impacts survival rates. Intraoperative radiotherapy (IORT) has shown promise in improving local disease control rates. However, determining the risk of progression in patients initially assessed as stable disease (SD) after IORT remains challenging....Read more
2019 26 Aug
Summary: Cancer affects everybody's life at some point. ‘The Death of Cancer,' written by one of oncology's leading figures, Dr Vincent T. DeVita, documents his own journey for the cure. Dr Peter Kapitein gives his personal review on the book. In 2005 I was diagnosed with lymph gland cancer and became interested in the medical industrial...Read more
2017 12 Dec
Johns Hopkins researchers have developed a new simple molecular test to detect chromosomal abnormalities — biomarkers known as telomere fusions — in pancreatic tumour specimens and cyst fluids. The detection of telomere fusions will help physicians determine which pancreatic lesions are likely to develop into cancer requiring surgical resection, according...Read more
2017 10 May
A systematic review concludes that different imaging modalities, except for positron emission tomography (PET), have comparable sensitivity, specificity and diagnostic accuracy for the diagnosis of pancreatic ductal adenocarcinoma. The findings are published in European Journal of Radiology. See Also : Benefit-Risk Assessment in Diagnostic Imaging...Read more
2016 31 May
Tumours have grown around the pancreas to encompass critical blood vessels in about a third of all pancreatic cancer patients, with conventional wisdom suggesting that surgery to remove the tumours is rarely an option, and life expectancy is usually measured in months. Now, Mayo Clinic has teamed up oncologists, radiologists, gastrointestinal...Read more
2015 09 Apr
A magnetic resonance imaging (MRI)-based screening programme for individuals at high risk of pancreatic cancer detected pancreatic lesions in 16 of 40 (40 percent) of patients, of whom five underwent surgery, according to a study published online in JAMA Surgery . “An MRI-based protocol for the surveillance of individuals at risk for developing pancreatic...Read more
2014 08 Oct
Medical education is evolving and is no longer restricted to on-campus learning. With the use of modern technology, learners can now access educational material at any time and from anywhere in the world with internet access. The ecancer Post Graduate School of Surgery Surgical Oncology Modules (ePOSSOM) has recently launched a series of innovative...Read more
2014 11 Mar
Together with researchers from around the UK, a team of oncologists from The Clatterbridge Cancer Centre has been conducting a project to develop a ground-breaking cancer vaccine that can be utilised alongside traditional treatment methods in order to fight pancreatic cancer. Pancreatic cancer is the fifth biggest cause of cancer related deaths,...Read more